Reuters logo
BRIEF-Indivior enters into settlement with Mylan Pharmaceuticals in patent infringement case
2017年9月25日 / 早上6点21分 / 1 个月内

BRIEF-Indivior enters into settlement with Mylan Pharmaceuticals in patent infringement case

Sept 25 (Reuters) - Indivior Plc

* INDIVIOR ENTERS INTO SETTLEMENT WITH MYLAN PHARMACEUTICALS IN PATENT INFRINGEMENT CASE

* A SETTLEMENT AGREEMENT WITH MYLAN PHARMACEUTICALS RESOLVING PATENT LITIGATION RELATED TO SUBOXONE SUBLINGUAL FILM

* INDIVIOR - LITIGATION HAS BEEN PENDING IN U.S. DISTRICT COURT FOR DISTRICT OF DELAWARE AND RESULTED FROM MYLAN‘S SUBMISSION OF AN ABBREVIATED NEW DRUG APPLICATION (ANDA) TO U.S. FDA

* TERMS OF SETTLEMENT ARE CONFIDENTIAL

* AS REQUIRED BY LAW, PARTIES WILL SUBMIT SETTLEMENT AGREEMENT TO U.S. FEDERAL TRADE COMMISSION AND U.S. DEPARTMENT OF JUSTICE FOR REVIEW Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below